01—Abstract
Summary
Summary of the 8-K filed May 11, 2026. Cited figures are marked; the original filing is the authoritative source.
Moderna, Inc. (MRNA) filed an 8-K on May 11, 2026, detailing key governance changes and outcomes from its 2026 Annual Meeting of Stockholders.
The Board of Directors adopted a by-law amendment designating federal district courts as the exclusive forum for Securities Act of 1933 claims, aligning with recent Delaware corporate law changes. This aims to streamline litigation and provide a more predictable legal environment for such disputes. Additionally, the filing reports the results of the Annual Meeting held on May 6, 2026.
Stockholders overwhelmingly re-elected the Class II directors, approved executive compensation on an advisory basis, and voted for annual advisory votes on executive compensation. The appointment of Ernst & Young LLP as the independent registered public accounting firm for fiscal year 2026 was also ratified with strong support. These outcomes reflect continued shareholder confidence in the company's leadership and financial oversight.
02—Key points
Key Highlights
- Moderna's Board amended its by-laws to establish federal district courts as the exclusive forum for Securities Act of 1933 claims.
- This by-law amendment is a response to recent changes in Delaware corporate law concerning forum selection.
- Stockholders re-elected all Class II directors to three-year terms.
- Executive compensation was approved on a non-binding advisory basis.
- Stockholders voted to hold advisory votes on executive compensation annually.
- Ernst & Young LLP was ratified as the independent registered public accounting firm for fiscal year 2026.
03—Questions
Frequently Asked Questions
What is the primary change introduced by the by-law amendment?
The primary change is the designation of federal district courts of the United States as the sole and exclusive forum for resolving complaints asserting causes of action arising under the Securities Act of 1933. This applies unless the company provides written consent for an alternative forum.
Why did Moderna implement this forum selection by-law?
Moderna implemented this amendment in response to recent changes in the General Corporation Law of the State of Delaware regarding forum selection provisions, aiming to provide a consistent and potentially more efficient legal venue for securities-related litigation.
What were the key outcomes of the 2026 Annual Meeting of Stockholders?
The key outcomes include the re-election of directors, advisory approval of executive compensation, a vote to hold future executive compensation advisory votes annually, and the ratification of Ernst & Young LLP as the independent auditor for fiscal year 2026.
How often will stockholders vote on executive compensation in the future?
Following the stockholder vote at the Annual Meeting, Moderna has determined that it will hold future advisory, non-binding votes on the compensation of its named executive officers on an annual basis.
04—Continue